Novel Lipid Lowering Therapy Against Coronary atherosclerosis: Role of PCSK9 Inhibitors - Masayuki Yoshida
Simple Education
1,189 videos
Summary
Novel Lipid Lowering Therapy Against Coronary atherosclerosis: Role of PCSK9 Inhibitors - Presented by Masayuki Yoshida at ISCP 2017.
Read More
Summary
Novel Lipid Lowering Therapy Against Coronary atherosclerosis: Role of PCSK9 Inhibitors - Presented by Masayuki Yoshida at ISCP 2017.
About Simple Education
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Works at Tokyo Medical and Dental Univeristy, Toyko, Japan. Features in 1 video on Wondr Medical. Masayuki Yoshida...
Works at Tokyo Medical and Dental Univeristy, Toyko, Japan. Features in 1 video on Wondr Medical. Masayuki Yoshida generally speaks on Aorta, Coronary arteries, PCSK9 Antagonists, and Anti-Platelet Drugs .
Start a conversation